Cite
Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo.
MLA
Kellie, John F., et al. “Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo.” Journal of Pharmaceutical Sciences, vol. 108, no. 4, Apr. 2019, pp. 1415–22. EBSCOhost, https://doi.org/10.1016/j.xphs.2018.11.019.
APA
Kellie, J. F., Thomson, A. S., Chen, S., Childs, S. L., Karlinsey, M. Z., Mai, S. H., White, J. R., & Biddlecombe, R. A. (2019). Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo. Journal of Pharmaceutical Sciences, 108(4), 1415–1422. https://doi.org/10.1016/j.xphs.2018.11.019
Chicago
Kellie, John F., Andrew S. Thomson, Shugui Chen, Sarah L. Childs, Molly Z. Karlinsey, Shing H. Mai, John R. White, and Robert A. Biddlecombe. 2019. “Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo.” Journal of Pharmaceutical Sciences 108 (4): 1415–22. doi:10.1016/j.xphs.2018.11.019.